Friday, December 1, 2017

Agony Aunt Claire gives advice on dealing with an office crush


ADVANCED psychotherapist and clinical hypnotherapist CLAIRE GASKIN sees clients in Essex and in London’s Harley Street. She is now bringing her expertise to the problems of our readers as our agony aunt.
If you have a problem you’d like Claire’s advice with, email agonyaunt@nqe.com For more details on Claire’s work, visitbenefittherapy.co.uk/

Dear Claire, I feel really embarrassed about this but there is someone at work who I really like and I think she likes me but I don’t know how to approach it.

We work in the same department and I think we get on well.

We are both single and of a similar age and I really want to ask her out. Do you think it’s a good idea ? Since we work together, if I have read the signs wrong then it will be really awkward.

Could I be imagining she is flirting with me ? The office Christmas do is coming up and I am wondering if I should make a move then but it would be awful to wake up the next day and regret anything.

I feel like a silly teenager and am thinking maybe I should just forget it and try other ways of meeting someone.

Claire says: People mostly regret the opportunities they let pass them by.

Various hormones are released when we are attracted to someone, which can play havoc with our thoughts and feelings.

Rest assured that if we think someone is flirting with us they usually are.

Body language is processed at subconscious levels and, although we might very occasionally pick up the wrong signals, it’s usually a lack of confidence which leads us to doubt our instincts.

A session or two of hypnotherapy can really help to build confidence, if this sounds familiar.

Did you know the office is statistically one of the best places to meet a romantic partner?

I think the Christmas do is a great time to ask your colleague out.

A trip to the cinema is a perfect first date: You learn to feel comfortable in their close company and avoid awkward silences afterwards because you have a shared experience to talk about.

Decide on a movie before the party and then strike up a conversation with your crush.

Say you’re looking forward to seeing this film and invite her along.

If she turns you down you can still hold your head up the next day.

However, there’s every chance she will say yes. I say, go for it!





All Hypnosis Feeds

Thorne lays coins aside for murder

  1. Thorne lays coins aside for murder  Numismatic NewsFull coverage




All Hypnosis Feeds

“Significant loss of neurons is a normal part of ageing” and other brain cell myths

GettyImages-480406339.jpgBy Christian Jarrett

Basic facts about the brain are a key part of many introductory psychology courses, including information about brain cells. For instance, for years, students (and the public) have been taught that, thanks to the ageing process, the older we get, the more brain cells we lose. But as outlined in a new review in the Journal of Chemical Neuroanatomy by Christopher von Bartheld at the University of Nevada, many established facts about brain cells (like the idea we lose lots of them as we get older) have been shown by modern techniques to be misconceptions. Taken mostly from the review, here are four myths about brain cells, plus one unresolved issue.

Myth: Significant loss of neurons is a normal part of ageing

Studies into brain cell loss conducted in the 1950s to 1980s, mostly on animal brains, painted a dispiriting picture. The findings suggested we lose about one per cent of our brain cells per year through adulthood, meaning that the brains of the elderly were estimated to have lost between 35 per cent to 55 per cent of their peak number. Through the 70s and 80s this led to the received wisdom that neuronal “fall out” is a normal part of ageing and contributes to loss of intellectual prowess in old age. von Bartheld even speculates that this widespread misconception may have led to the observed spike in suicidal ideation among older people in the 70s and 80s, “since mental decline is among the disabilities most feared in old age”.

In fact, it’s now known that these early estimates of brain cell loss through age were distorted by a failure to adjust for the brain shrinkage associated with ageing. Although older brains get smaller, they retain most of their neurons (which become more densely packed). Using more modern techniques that adjusted for shrinkage, studies through the 1990s and 2000s either found no neuronal loss or minimal loss with ageing. Combining data from all these different studies, the best estimate is that ageing leads to just a 2 to 4 per cent loss of neurons across the lifespan. “It now appears well-established that cortical neuron numbers in humans decline very little during normal ageing,” writes von Bartheld, “and intellectual decline with age may rather be due to numerical reductions of relatively small, specific neuronal populations, or changes in ageing neurons’ chemistry or morphology.”

Myth: Glial cells are mere housekeeping cells

Cells in the brain can be crudely divided into neurons and glial cells. Until very recently, most research and interest has been on neurons, with glial cells either ignored or seen as occupying a kind of support role or house-keeping function for the neurons. However, and as I report in Great Myths of the Brain, it’s now known that some glial cells (specifically astrocytes) have a direct role in information processing in the brain because they can influence the signalling that goes on between neurons. They even seem to play an architectural role in neural networks, helping to create and eliminate synapses (the points of communication) between neurons. Based on this, a key researcher in this area, Maiken Nedergaard, says that we should see glial cells not as the servants of neurons, but as their parents.

Myth: Glial cells outnumber neurons 10 to 1

Given that glial cells are incredibly important, including being involved in cognitive functioning, it’s rather alarming that for many decades we collectively had a complete misunderstanding of how many of these cells there are – the popular estimate, considered “common knowledge”, was that there are approximately ten times as many of them as there are neurons. Part of the reason for the perseverance of this wildly mistaken figure was that it was cited with authority in numerous editions of the “bible of neuroscience”, Nobel laureate Eric Kandel’s Principles of Neural Science.

von Bartheld says the myth originated from studies in 1960s that focused on cells counts in parts of the brainstem where glial cells do dramatically outnumber neurons. Counter evidence was largely overlooked until the 2000s when a new technique was developed for counting cells – isotropic fractionation – which effectively turns the whole brain into a soup-like state allowing the easy and accurate counting of different cell types across the entire brain. Pioneering work by Brazilian neuroscientist Suzana Herculano-Houzel using this technique has established there are roughly equal numbers of glial cells and neurons. “The concept that glial cells are not more abundant than neurons in human brains is now becoming increasingly accepted in the field,” writes von Bartheld.

Myth: Alcohol abuse causes widespread major brain cell loss

Alcohol abuse is clearly harmful to health in general and to our brains in particular. However, yet another misconception related to brain cells, at least in the 1970s and 1980s, was that they are literally destroyed throughout the brain by excessive alcohol consumption. von Bartheld says this idea originated from animal studies that showed exposure to alcohol did indeed lead to significant, widespread loss of neurons or glial cells. The present understanding, he says, is that in humans, alcohol abuse mostly harms the fatty insulation (the “white matter”) that surrounds the axons of neurons, which will impair functioning but not lead to cell death. However, some neuronal loss can occur in especially vulnerable regions, principally the frontal cortex. “This refined concept of regional, restricted losses provides more hope to former and recovering alcoholics,” von Bartheld writes, “because axonal (white matter) and myelination deficits may be potentially reversible, while dead neurons in the central nervous system generally cannot be replaced.” As for moderate alcohol consumption, various authorities state that this will not kill your brain cells. For instance on its Brain Facts website, the Society for Neuroscience states plainly: “Moderate amounts of alcohol do not kill brain cells”.

Unresolved issue: Men have more neurons, on average, than women

It’s an established fact that men’s brains are bigger, on average, than women’s, but does that also equate to having more brain cells? Not necessarily because it’s possible that the cells are packed more densely into the female brain. Based on a combination of data from four major studies published in the 1990s and 2000s, together involving 80 male brains and 73 female brains, von Bartheld estimates that men average 16 per cent more neurons than women (“23.7 billion cortical neurons in males vs. 19.8 billion cortical neurons in females”). However, given the lack of studies using the modern isotropic fractionation (brain soup) technique, and also taking into account “the considerable variability between individuals”, von Bartheld says that while it is likely that men average a greater number of neurons, this has yet to be “conclusively shown”. It’s perhaps also worth adding that more neurons doesn’t equate to greater intelligence (and that average IQ is virtually identical across the two sexes). “It is … possible,” says von Bartheld, “that instead of neuron number, the number of synapses and/or circuits is the crucial parameter for intelligence.”

Overall, when it comes to studying the basic cellular make-up of the human brain, von Bartheld says that “we need to be vigilant about assumptions that are taken for granted, as shown by the evidence that ‘text-book knowledge’ may not be correct.” Something for us to bear in mind when studying Biological Psychology 101. In the brain cell field, von Bartheld adds that “it is important to keep an open mind and be inquisitive and creative, in order to separate truths from myths” – wise words that might fairly be applied to any form of scientific discovery.

Myths and truths about the cellular composition of the human brain: A review of influential concepts






All Hypnosis Feeds

How To Improve Mind, Lose Weight And Build Your Muscle?

  1. How To Improve Mind, Lose Weight And Build Your Muscle?  Daily PioneerFull coverage




All Hypnosis Feeds

The life-changing benefits of hypnotherapy

With the Christmas party season almost upon us, are you trying to lose a bit of weight? Are your thoughts along the lines of ‘Well, I was good, but I’ve not got any willpower’?

Dealing with weight management issues and trying to maintain a healthy diet can be difficult. So many people give up after a week or two and they cite so many reasons which are, in reality, an all-too handy convenience to go back to the old ways of overeating.

Snacking is a real issue for many people. And, like so many other things we are told we shouldn’t do, it’s a habit. If you’re really serious about wanting to lose weight then it’s an unwanted habit.

Hypnotherapy can help replace your unwanted habits with healthier ones. And the great thing is, you are in charge! You are fully awake, completely in control. All you have to do is sit back and listen to me putting suggestions to your subconscious mind. Hypnotherapy is a relaxing, calm process which can bring about the necessary behavioural changes to help you achieve your goals.

One of my clients has lost nearly two stones in just four months. He told me he loves the hypnotherapy process and has now cut out snacking on crisps, chocolate and bread rolls.

The cost of a session of hypnotherapy at Mind Generating Success is just £60. The number of sessions depends on how well it works but many of my clients have stopped their unwanted habits after just four sessions. And think how much slimmer, healthier and fitter you will feel. As well as the money saved by no longer buying ‘snacking’ food!

It’s not only weight loss that hypnotherapy can help with. It can help you quit smoking and deal with other addictions. One of my clients told me he has tried everything from nicotine gum, to patches to going cold turkey. Nothing worked – until hypnotherapy.

Now, there can be many reasons why you smoke. And you may think nothing works and you’ll never be able to give up the ciggies. However once an assessment has been made – and, crucially, you really want to give up smoking, one session may be all you need.

Someone smoking 20 cigarettes a day can spend an astonishing £3,000 a year on tobacco. Think what you could do with that money? And you’ll be healthier to boot! One session of smoking cessation hypnotherapy costs just £95 – and it’s a method that works!
Hypnotherapy can also help people who have anxiety. Anxious feelings can in some cases be accompanied by acute stress, physical symptoms or panic attacks.

Although anxiety is a normal reaction to stressful situations – family concerns, pressure of work etc. – its impact on your day-to-day living can become severe and the effect on the quality of life overwhelming. Hypnotherapy can help you reduce anxiety and reduce the stress in your life.
Okay, you’re keen to find out more. So, what should you do?

If you interested in losing weight, stopping smoking, reducing anxiety or have a phobia such as a fear of spiders, mice, insects, dogs or cats – or you have a fear of flying – take the first step to changing your life by contacting me today for an initial consultation.
Evening appointments available. Home visits by arrangement.

Mike Smith Hyp CS
Mind Generating Success
Craiglockhart
Edinburgh EH14 1DJ
Tel: 07521 353 787
Email: mike.smith@mgs-hypnotherapy-services.co.uk
http://ift.tt/2w2Txvz





All Hypnosis Feeds

Insomnia Market Projected to Gain Significant Value by 2026 End

Source: Press Release

Global Insomnia Market: Brief Account 

The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases such as cancer at the forefront. The launch of new products such as E-2006 by Eisai Co. Ltd. and Belsomra by Merck & Co. Inc. is forecasted to stimulate the market growth handsomely.

The global insomnia market could be segmented according to over-the-counter (OTC) treatment, non-pharmacological treatments, and pharmacological treatments, where each category is evaluated to contribute their part toward the global growth.

Report Overview and TOC @ http://ift.tt/2jwxFVB

The researchers who have authored this report prioritize painstaking primary and secondary research to compile statistical data and other analytics of the global insomnia market. Players in the market can gain a decisive insight into the guidelines required to extend their portfolio in the right direction and achieve a tangible success in the market. 

Global Insomnia Market: Key Trends 

With the two premier categorizations of the worldwide insomnia market into play, viz. non-pharmacological treatments and pharmacological treatments, manufacturers can expect lucrative prospects from both the segments. The cognitive behavioral therapy for insomnia (CBTI) listed under non-pharmacological treatments extends the ability of physicians to heal patients or understand their health issues in a comprehensive manner. Such treatments including hypnotherapy can be employed by doctors to take multiple approaches during the treatment of their patients. There are other treatments such as aroma music, bright light, biofeedback, acupuncture, and yoga therapies which could contribute to the growth of the non-pharmacological treatments market.

Request for Broucher @  http://ift.tt/2hDrgaj

Likewise, pharmacological treatments are prognosticated to lay a strong platform for the global insomnia market to find more growth prospects on the back of key segments such as OTC sleep aids and prescription sleep aids.

The international insomnia market could go through a downtime period due to inferior diagnosis rate, below par patient compliance, patent erosion, and ascendancy of generic products. Howbeit, the surging incidences of insomnia and unfulfilled medical needs, for instance, the inefficiency of central nervous system (CNS) drugs, are foreseen to compensate for the probable decline in growth. 

Global Insomnia Market: Geographical Study 

For the most part of the share in world insomnia market, the Americas including North America are foretold to showcase extensive dominance while offering some groundbreaking opportunities for global players. In the U.S., the OTC treatment market is anticipated to register a higher CAGR to address its growth in the insomnia pharmacological treatment sector. The OTC sleep aids market can be classified into valerian roots, melatonin, and antihistamines. An increasing number of patients are convinced to adopt OTC sleep aids because of the infamous side effects caused by prescription drugs and low prices and easy availability of OTC treatments. The U.S. insomnia market is predicted to gain support from the rising consumption of valerian roots and melatonin, owing to their crucial advantages such as decreased stress levels and less side effects.

For Specific and Customized Requirements @ http://ift.tt/2BA9CJM

The Americas could be followed by Europe, the Middle East, and Africa on account of the augmenting interest in spreading health awareness through various programs and inflating geriatric population. The insomnia market in Asia Pacific is also looked upon as a decent opportunity for vendors to capitalize on with the elevating disposable income and upsurge in the occurrence of chronic diseases. 

Global Insomnia Market: Top Companies 

Some of the prominent companies functioning in the international insomnia market are Purdue Pharma L.P., Pernix Therapeutics, Takeda Pharmaceutical Company Ltd., Sanofi, Pfizer, Inc., Meda Consumer Healthcare Inc., Merck & Co. Inc., and Eisai, Co. Ltd.

Pre Book Full Report @ http://ift.tt/2kd6gZ7





All Hypnosis Feeds

Insomnia Market Projected to Gain Significant Value by 2026 End

Global Insomnia Market: Brief Account 

The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases such as cancer at the forefront. The launch of new products such as E-2006 by Eisai Co. Ltd. and Belsomra by Merck & Co. Inc. is forecasted to stimulate the market growth handsomely.

The global insomnia market could be segmented according to over-the-counter (OTC) treatment, non-pharmacological treatments, and pharmacological treatments, where each category is evaluated to contribute their part toward the global growth.

Report Overview and TOC @ http://ift.tt/2jwxFVB

The researchers who have authored this report prioritize painstaking primary and secondary research to compile statistical data and other analytics of the global insomnia market. Players in the market can gain a decisive insight into the guidelines required to extend their portfolio in the right direction and achieve a tangible success in the market. 

Global Insomnia Market: Key Trends 

With the two premier categorizations of the worldwide insomnia market into play, viz. non-pharmacological treatments and pharmacological treatments, manufacturers can expect lucrative prospects from both the segments. The cognitive behavioral therapy for insomnia (CBTI) listed under non-pharmacological treatments extends the ability of physicians to heal patients or understand their health issues in a comprehensive manner. Such treatments including hypnotherapy can be employed by doctors to take multiple approaches during the treatment of their patients. There are other treatments such as aroma music, bright light, biofeedback, acupuncture, and yoga therapies which could contribute to the growth of the non-pharmacological treatments market.

Request for Broucher @  http://ift.tt/2hDrgaj

Likewise, pharmacological treatments are prognosticated to lay a strong platform for the global insomnia market to find more growth prospects on the back of key segments such as OTC sleep aids and prescription sleep aids.

The international insomnia market could go through a downtime period due to inferior diagnosis rate, below par patient compliance, patent erosion, and ascendancy of generic products. Howbeit, the surging incidences of insomnia and unfulfilled medical needs, for instance, the inefficiency of central nervous system (CNS) drugs, are foreseen to compensate for the probable decline in growth. 

Global Insomnia Market: Geographical Study 

For the most part of the share in world insomnia market, the Americas including North America are foretold to showcase extensive dominance while offering some groundbreaking opportunities for global players. In the U.S., the OTC treatment market is anticipated to register a higher CAGR to address its growth in the insomnia pharmacological treatment sector. The OTC sleep aids market can be classified into valerian roots, melatonin, and antihistamines. An increasing number of patients are convinced to adopt OTC sleep aids because of the infamous side effects caused by prescription drugs and low prices and easy availability of OTC treatments. The U.S. insomnia market is predicted to gain support from the rising consumption of valerian roots and melatonin, owing to their crucial advantages such as decreased stress levels and less side effects.

For Specific and Customized Requirements @ http://ift.tt/2BA9CJM

The Americas could be followed by Europe, the Middle East, and Africa on account of the augmenting interest in spreading health awareness through various programs and inflating geriatric population. The insomnia market in Asia Pacific is also looked upon as a decent opportunity for vendors to capitalize on with the elevating disposable income and upsurge in the occurrence of chronic diseases. 

Global Insomnia Market: Top Companies 

Some of the prominent companies functioning in the international insomnia market are Purdue Pharma L.P., Pernix Therapeutics, Takeda Pharmaceutical Company Ltd., Sanofi, Pfizer, Inc., Meda Consumer Healthcare Inc., Merck & Co. Inc., and Eisai, Co. Ltd.

Pre Book Full Report @ http://ift.tt/2kd6gZ7





All Hypnosis Feeds